Schonfeld Strategic Advisors LLC Abbott Laboratories Transaction History

Schonfeld Strategic Advisors LLC

$13.8 Billion
Q3 2024

A detailed history of Schonfeld Strategic Advisors LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 21,711 shares of ABT stock, worth $2.48 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

21,711

Previous 78,750 72.43%

Holding current value

$2.48 Million

Previous $8.18 Million 69.75%

% of portfolio

0.02%

Previous 0.06%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$100.07 - $118.13 $5.71 Million - $6.74 Million	-57,039 Reduced 72.43%	21,711 $2.48 Million
Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $2.44 Million - $2.73 Million	-24,260 Reduced 23.55%	78,750 $8.18 Million
Q1 2024 May 15, 2024	BUY	$109.52 - $120.96 $1.74 Million - $1.93 Million	15,925 Added 18.29%	103,010 $11.7 Million
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $3.47 Million - $4.24 Million	38,422 Added 78.96%	87,085 $9.59 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $4.27 Million - $5.12 Million	44,679 Added 1121.46%	48,663 $4.71 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $8.04 Million - $8.96 Million	-79,759 Reduced 95.24%	3,984 $434,000
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $4.79 Million - $5.64 Million	-49,428 Reduced 37.12%	83,743 $8.48 Million
Q4 2022 Feb 14, 2023	SELL	$95.06 - $111.52 $4.68 Million - $5.49 Million	-49,209 Reduced 26.98%	133,171 $14.6 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $8.72 Million - $10.1 Million	90,085 Added 97.61%	182,380 $17.6 Million
Q2 2022 Aug 15, 2022	BUY	$102.07 - $123.37 $30,110 - $36,394	295 Added 0.32%	92,295 $10 Million
Q1 2022 May 16, 2022	BUY	$114.02 - $139.04 $9.64 Million - $11.8 Million	84,526 Added 1130.93%	92,000 $10.9 Million
Q4 2021 Feb 14, 2022	SELL	$115.53 - $141.46 $8.94 Million - $10.9 Million	-77,400 Reduced 91.19%	7,474 $1.05 Million
Q3 2021 Nov 16, 2021	BUY	$116.66 - $129.06 $527,303 - $583,351	4,520 Added 5.63%	84,874 $10 Million
Q2 2021 Aug 16, 2021	BUY	$105.79 - $124.53 $5.04 Million - $5.93 Million	47,654 Added 145.73%	80,354 $9.32 Million
Q1 2021 May 17, 2021	SELL	$108.84 - $128.23 $2.37 Million - $2.79 Million	-21,767 Reduced 39.96%	32,700 $3.92 Million
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $326,865 - $356,189	-3,113 Reduced 5.41%	54,467 $5.96 Million
Q3 2020 Nov 16, 2020	BUY	$91.64 - $111.29 $4.36 Million - $5.3 Million	47,580 Added 475.8%	57,580 $6.27 Million
Q2 2020 Aug 14, 2020	SELL	$76.57 - $98.0 $765,699 - $980,000	-10,000 Reduced 50.0%	10,000 $914,000
Q1 2020 May 15, 2020	BUY	$62.82 - $91.86 $102,710 - $150,191	1,635 Added 8.9%	20,000 $1.58 Million
Q4 2019 Feb 14, 2020	SELL	$78.51 - $87.4 $98,765 - $109,949	-1,258 Reduced 6.41%	18,365 $1.6 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $8.21 Million - $8.91 Million	-100,377 Reduced 83.65%	19,623 $1.64 Million
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $2.27 Million - $2.65 Million	31,200 Added 35.14%	120,000 $10.1 Million
Q1 2019 May 15, 2019	SELL	$66.22 - $80.06 $291,368 - $352,264	-4,400 Reduced 4.72%	88,800 $7.1 Million
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $2.83 Million - $3.21 Million	43,200 Added 86.4%	93,200 $6.74 Million
Q3 2018 Nov 14, 2018	BUY	$60.81 - $73.36 $3.04 Million - $3.67 Million	50,000 New	50,000 $3.67 Million
Q1 2018 May 15, 2018	SELL	$56.27 - $63.62 $752,161 - $850,408	-13,367 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $717,540 - $768,201	13,367	13,367 $763,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account

Schonfeld Strategic Advisors LLC Abbott Laboratories Transaction History